IANNITTO, EMILIO
 Distribuzione geografica
Continente #
NA - Nord America 1.168
EU - Europa 512
AS - Asia 498
SA - Sud America 75
AF - Africa 23
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.286
Nazione #
US - Stati Uniti d'America 1.148
SG - Singapore 186
RU - Federazione Russa 181
IT - Italia 109
CN - Cina 107
GB - Regno Unito 63
BR - Brasile 56
IN - India 38
HK - Hong Kong 37
VN - Vietnam 34
DE - Germania 31
IE - Irlanda 30
PL - Polonia 27
KR - Corea 18
JP - Giappone 16
FI - Finlandia 15
SE - Svezia 15
FR - Francia 13
CA - Canada 11
BD - Bangladesh 10
AU - Australia 9
IQ - Iraq 8
TR - Turchia 8
AR - Argentina 7
MX - Messico 7
NL - Olanda 7
BE - Belgio 4
CI - Costa d'Avorio 4
ID - Indonesia 4
MA - Marocco 4
PK - Pakistan 4
UZ - Uzbekistan 4
ZA - Sudafrica 4
EC - Ecuador 3
ET - Etiopia 3
PH - Filippine 3
TH - Thailandia 3
UA - Ucraina 3
UY - Uruguay 3
CO - Colombia 2
EG - Egitto 2
ES - Italia 2
GR - Grecia 2
IL - Israele 2
KE - Kenya 2
LK - Sri Lanka 2
MD - Moldavia 2
MY - Malesia 2
NO - Norvegia 2
OM - Oman 2
PY - Paraguay 2
SA - Arabia Saudita 2
SI - Slovenia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AT - Austria 1
BB - Barbados 1
BN - Brunei Darussalam 1
CG - Congo 1
CH - Svizzera 1
CR - Costa Rica 1
EU - Europa 1
GE - Georgia 1
HU - Ungheria 1
KZ - Kazakistan 1
LB - Libano 1
LY - Libia 1
NP - Nepal 1
PE - Perù 1
RW - Ruanda 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TW - Taiwan 1
VE - Venezuela 1
Totale 2.286
Città #
Fairfield 166
Ashburn 149
Singapore 121
Woodbridge 97
Chandler 70
Seattle 70
Wilmington 68
Houston 67
Cambridge 57
San Jose 42
Moscow 39
Hong Kong 35
Des Moines 28
Dublin 26
Beijing 24
Zgierz 23
Medford 19
Los Angeles 18
Ann Arbor 17
Altamura 16
Tokyo 14
Dearborn 12
San Diego 12
São Paulo 12
Lawrence 11
Princeton 11
Frankfurt am Main 10
Hanoi 10
Ho Chi Minh City 10
Nanjing 10
Palermo 9
Santa Clara 9
Dallas 8
Lauterbourg 8
New York 8
Chennai 7
Kumar 7
London 7
Milan 7
Orem 7
Boardman 6
Chicago 6
Falls Church 6
Islington 6
Jinan 6
Montreal 6
Rome 6
Ankara 5
Birmingham 5
Buffalo 5
Denver 5
Derby 5
Hefei 5
Hyderabad 5
Kolkata 5
Ludwigshafen am Rhein 5
Mumbai 5
Ningbo 5
Abidjan 4
Atlanta 4
Hebei 4
Helsinki 4
Johannesburg 4
Limbiate 4
Peterborough 4
Shenyang 4
Addis Ababa 3
Amsterdam 3
Beaverton 3
Blackmans Bay 3
Bucheon-si 3
Cinisello Balsamo 3
Columbus 3
Dawlish 3
Dhaka 3
Istanbul 3
Lappeenranta 3
Nanchang 3
Nuremberg 3
Phoenix 3
Pittsburgh 3
Pontefract 3
San Paolo di Civitate 3
Seoul 3
Tashkent 3
The Dalles 3
Tower Hamlets 3
Warsaw 3
Aberdeen 2
Antwerp 2
Bacolod City 2
Bangkok 2
Bologna 2
Bracknell 2
Brussels 2
Bundoora 2
Cairo 2
Chignolo d'Isola 2
Chongqing 2
Cleveland 2
Totale 1.560
Nome #
A rapidly progressive motor neuron disease associated to a natural killer cells leukaemia 392
Angioimmunoblastic T-cell lymphoma 225
Use of intrapleural bortezomib in myelomatous pleural effusion [1] 203
Rituximab with cyclophosphamide, vincristine, non-pegylated liposomal doxorubicin and prednisone as first-line treatment for splenic marginal zone lymphoma: A Fondazione Italiana Linfomi phase II study 198
Efficacy of bendamustine and rituximab in splenic marginal zone lymphoma: results from the phase II BRISMA/IELSG36 study 197
Response-guided ABVD chemotherapy plus involved-field radiation therapy for intermediate-stage hodgkin lymphoma in the pre-positron emission tomography era: A Gruppo Italiano Studio Linfomi (GISL) prospective trial 183
Are blood donors an adequate control group to ascertain HCV prevalence in non-Hodgkin’s lymphoma patients? 175
Gamma-delta T-cell lymphomas 164
Human cytomegalovirus glycoprotein B genotypes in immunocompetent, immunocompromised, and congenitally infected Italian populations 152
Re: "Splenic marginal zone B-cell lymphoma associated with primary Sjögren's syndrome" 134
Screening for celiac disease in non-Hodgkin's lymphoma patients: a serum anti-transglutaminase-based approach 134
Pseudotemporal ordering of spatial lymphoid tissue microenvironment profiles trails Unclassified DLBCL at the periphery of the follicle 106
Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study 100
Totale 2.363
Categoria #
all - tutte 8.113
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.113


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202131 0 0 0 0 0 0 0 0 0 0 12 19
2021/2022161 21 30 2 0 10 5 11 4 20 26 9 23
2022/2023227 11 51 0 18 29 37 22 12 23 8 10 6
2023/2024167 4 16 21 8 17 24 14 3 8 19 4 29
2024/2025258 14 28 8 23 22 11 8 11 19 23 33 58
2025/2026824 92 28 36 62 98 135 122 95 74 60 22 0
Totale 2.363